Caprelsa Tablet, Film Coated
Product Images NDC 58468-7840

4 FDA label images from Genzyme Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Caprelsa (NDC 58468-7840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (E5721cb8 4185 47b9 Bbb3 1c587e558a03 01)

Chemical Structure (E5721cb8 4185 47b9 Bbb3 1c587e558a03 01)
Chemical structure of Vandetanib, the active ingredient in CAPRELSA, showing the arrangement of atoms including nitrogen, oxygen, fluorine, bromine, and carbon in the molecule.*
FDA Label Image

Figure 1 (E5721cb8 4185 47b9 Bbb3 1c587e558a03 02)

Figure 1 (E5721cb8 4185 47b9 Bbb3 1c587e558a03 02)
A Kaplan-Meier survival curve showing progression-free survival over time in months for patients treated with Caprelsa 300 mg versus placebo. The solid line represents Caprelsa, and the dashed line represents placebo. The graph includes patient numbers at specified intervals and statistical information with hazard ratio, confidence interval, and p-value.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Carton)

Principal Display Panel (100 mg Tablet Bottle Carton)
Packaging label for Caprelsa (vandetanib) tablets 100 mg by Genzyme Corporation. The foldable carton indicates 30 film-coated tablets per bottle, stating 'Rx only' with instructions to dispense the enclosed medication guide. The label includes storage instructions and manufacturer details, with barcodes and the NDC 58468-7820-3 printed.*
FDA Label Image

Principal Display Panel (300 mg Tablet Bottle Carton)

Principal Display Panel (300 mg Tablet Bottle Carton)
Packaging label for Caprelsa (vandetanib) tablets, 300 mg strength. The label indicates oral film-coated tablets, with a quantity of 30 tablets per bottle. The labeler is Genzyme Corporation, a Sanofi company. The box includes dosage and storage warnings, the NDC 58468-7840-3, and directions to dispense an enclosed medication guide to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.